Profile: Biovest International, Inc. is a vertically-integrated specialty biopharmaceutical company with services to commercialize targeted therapeutics. We also develop, manufacture and market patented cell culture systems & equipment to pharmaceutical, diagnostic & biotechnology companies, as well as research institutions. The AutovaxID-C is our self-contained automated cell growth instrument. It has a small footprint, and functionally replaces conventional cell growth chambers that would take up over ten times the space. The ResCu-Primer HF is our hollow fiber cell culture system capable of producing small quantities of monoclonal antibody. This system also provides an option to evaluate the efficacy of new cell lines in perfusion technology.
The company was founded in 1981, has revenues of USD 10-25 Million, has ~10 employees and is CE certified. OTC:BVTI (SEC Filings)
3 Products/Services (Click for related suppliers)
|
• Cell Culture Suspension System (FDA Code: KJF / 864.2240) Cell and tissue culture supplies and equipment are devices that are used to examine, propagate, nourish, or grow cells and tissue cultures. These include such articles as slide culture chambers, perfusion and roller apparatus, cell culture suspension systems, and tissue culture flasks, disks, tubes, and roller bottles. |
• Perfusion Apparatus (FDA Code: KJH / 864.2240) |
• Therapeutic Cancer Vaccines |